FDA Lifts Restrictions on Spinal Cord Stimulation System
By Admin | January 22, 2022
The US Food and Drug Administration (FDA) has approved updated labeling that expands MRI compatibility for Abbot’s Proclaim XR spinal cord stimulation (SCS) system, the company announced.
The FDA originally approved the Proclaim XR neurostimulation system for patients with chronic pain in 2019, as reported at the time by Medscape Medical News...(More)
For more info please read, FDA Lifts Restrictions on Spinal Cord Stimulation System, by Medscape
